0.0NOK
267.00 KNOK
500.66 MNOK
26.22 M
About PHOTOCURE ASA
Sector
Industry
CEO
Daniel Schneider
Website
Headquarters
Oslo
Founded
1993
ISIN
NO0010000045
FIGI
BBG000CQ2XB1
Photocure ASA engages in the development and commercialization of pharmaceutical products based on photodynamic technology. Its products include Metvix for nonmelanoma skin cancer, Hexvix/Cysview for better detection and management of bladder cancer, and Cevira which is a photodynamic drug-device combination product for non-surgical treatment of high-grade cervical dysplasia. The company operates through the Commercial Franchise and Development Portfolio segments. The Commercial Franchise segment includes the sale of Hexvix/Cysview in the U.S. and Europe and other sales from partners and other products. The Development Portfolio segment focuses on the development of pipeline products. The company was founded in 1997 and is headquartered in Oslo, Norway.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PHO is 54.5 NOK — it has decreased by 2.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange PHOTOCURE ASA stocks are traded under the ticker PHO.
PHOTOCURE ASA is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for PHOTOCURE ASA has a max estimate of 87.0 NOK and a min estimate of 85.0 NOK.
PHO earnings for the last quarter are −0.18 NOK whereas the estimation was −0.43 NOK which accounts for 58.77% surprise. Estimated earnings for the next quarter are −0.11 NOK. See more details about PHOTOCURE ASA earnings.
PHOTOCURE ASA revenue for the last quarter amounts to 107.50 M NOK despite the estimated figure of 111.46 M NOK. In the next quarter revenue is expected to reach 127.58 M NOK.
Yes, you can track PHOTOCURE ASA financials in yearly and quarterly reports right on TradingView.
Like other stocks, PHO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHOTOCURE ASA stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHOTOCURE ASA EBITDA is 152.58 M NOK, and current EBITDA margin is 30.48%. See more stats in PHOTOCURE ASA financial statements.